医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mannatech Hosts 7,000 at Asia MannaFest℠ Event

2014年10月06日 PM10:00
このエントリーをはてなブックマークに追加


 

COPPELL, Texas

Mannatech®, Incorporated (NASDAQ: MTEX), the pioneer of nutritional glycobiology, leading innovator of naturally-sourced supplements based on Real Food Technology® solutions and creator of the M5MSM (Mission 5 MillionSM) social entrepreneurial movement, hosted its second annual Asia MannaFest event on October 1, 2014 in Seoul, South Korea. The event was held at Handball Stadium in Olympic Park and over 7,000 tickets were sold to participants from Korea, Japan, Taiwan and Hong Kong.

Asia MannaFest’s celebration of 10 years of operation in Korea coincided with the 20-year anniversary of the founding of Mannatech. Chairman of the Board J. Stanley Fredrick, CEO and Chief Science Officer Dr. Robert Sinnott, President Al Bala, Co-Founder and Board Member Ray Robbins and Senior Wellness Director Dr. Steve Nugent were all in attendance to show their support for Mannatech Korea and its role in Mannatech’s rapidly expanding global market.

Featured presentations focused on Mannatech’s expanded global vision, the M5M China Run and the introduction of several new skin and beauty care products. Associates who demonstrated outstanding leadership and business achievements were recognized from stage and a performance by Korean Pop Musician Beomsoo Kim was also held during the main session. Mannatech’s mission to improve lives through the health benefits of their products and the financial benefits of their leveraged-based income model was a consistent theme throughout the event.

“Mannatech’s business model is full of potential,” said Dr. Robert Sinnott during a special presentation. “The combination of high-quality products based on science, ingredients that are naturally derived and a seamless compensation plan makes Mannatech a ‘Super Company.’ I believe that, if you’re with Mannatech, nothing is impossible.”

Individuals interested in Mannatech’s products, or exploring its business opportunity, can learn more at Mannatech.com.

About Mannatech

Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, United Kingdom, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico and Hong Kong. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

CONTACT

Mannatech, Incorporated
Ben Hulet, 972-471-7224
bhulet@mannatech.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
  • Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
  • ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu neuartigem Antikörper-Wirkstoff-Konjugat ADCT-402
  • Bertin与Zymo Research宣布达成新的合作